|
Market Closed -
London S.E.
11:35:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 39.50 GBX | -1.25% |
|
-3.66% | -78.06% |
| 08-27 | Faron Pharmaceuticals Announces First Patient Enrolled in BEXAR Investigator-Initiated Trial | CI |
| 08-26 | EARNINGS and TRADING: Empresaria ups guidance as cost cuts bear fruit | AN |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.25% | -3.66% | -5.95% | -15.96% | -78.06% | -80.25% | -87.26% | -90.65% | -84.20% | 110M | |
| -0.25% | -0.92% | +20.22% | +51.97% | +70.34% | +49.47% | +89.45% | +16.27% | - | 68.13B | |
| +1.21% | +0.80% | +18.95% | +23.43% | +23.63% | +46.29% | +85.32% | +211.28% | +6,252.69% | 63.6B | |
| +1.31% | +1.81% | +27.72% | +48.41% | +57.38% | +49.04% | +12.07% | -58.90% | - | 25.57B | |
| -0.25% | -1.92% | +23.24% | +14.60% | -30.18% | -10.72% | +436.70% | +317.13% | +807.47% | 26.6B | |
| +0.33% | -10.61% | +12.55% | +11.17% | +7.09% | +1.95% | -16.27% | -69.34% | - | 25.52B | |
| -6.09% | -11.19% | +23.58% | +56.25% | +209.18% | +224.80% | +351.08% | +1,722.16% | +883.30% | 18.23B | |
| +1.18% | +1.66% | +15.52% | +26.00% | +5.92% | +35.20% | -18.67% | -28.00% | +101.41% | 19.69B | |
| -1.49% | -6.35% | +1.24% | +6.02% | +24.89% | +7.84% | +540.26% | - | - | 15.16B | |
| +4.12% | +0.30% | +7.28% | +13.15% | +29.80% | +52.03% | +150.18% | +191.15% | +401.23% | 13.54B | |
| -0.24% | +5.18% | +15.28% | +11.94% | -7.49% | +23.04% | +190.97% | +543.93% | +4,434.60% | 12.48B | |
| +0.42% | -6.91% | -2.26% | +10.03% | +24.63% | +275.58% | +195.92% | +20.81% | +1,071.95% | 11.64B | |
| -4.73% | -3.06% | -8.83% | -27.48% | -24.20% | -44.99% | +148.62% | +113.06% | - | 10.56B | |
| +3.96% | +5.99% | +8.76% | -9.87% | -19.04% | -40.25% | +768.71% | +94.51% | +112.96% | 10.87B | |
| +0.69% | -7.82% | -7.43% | -3.09% | +12.37% | +102.09% | +98.33% | +116.23% | +580.00% | 9.86B | |
| +0.13% | +0.11% | +1.71% | +146.09% | +82.49% | +174.12% | +387.10% | +254.25% | - | 9.01B | |
| +0.12% | -0.46% | +12.44% | +24.33% | +31.79% | +97.50% | +14.52% | +125.89% | - | 9.04B | |
| -1.01% | -3.91% | +9.76% | +8.70% | +297.47% | +236.32% | +414.38% | -33.31% | - | 8.43B | |
| -1.67% | +6.94% | -2.94% | -3.99% | +10.21% | -19.15% | +116.80% | -21.04% | - | 8.55B | |
| -0.93% | -17.57% | -10.00% | +25.46% | +170.15% | +436.69% | +510.34% | -51.17% | -38.81% | 7.88B | |
| Average | -0.17% | -2.00% | +8.04% | +20.86% | +44.92% | +80.83% | +219.43% | +177.59% | +1,320.24% | 18.72B | |
| Weighted average by Cap. | +0.06% | -2.12% | +14.11% | +27.67% | +44.49% | +64.74% | +178.83% | +183.95% | +2,658.88% |
- Stock Market
- Stocks
- FARN Stock
- Sector Faron Pharmaceuticals Oy
Select your edition
All financial news and data tailored to specific country editions
